Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HILT in Greater Trochanteric Pain Syndrome

NCT: NCT07749066 · RECRUITING

NCT IDNCT07749066
StatusRECRUITING
Start Date2026-06-01
Completion2027-07-30
SponsorAnkara Etlik City Hospital (OTHER_GOV)
First posted
Last updated

Brief Summary

Greater Trochanteric Pain Syndrome (GTPS) is a common cause of lateral hip pain that can significantly impair daily activities and quality of life. Conservative treatments, including physical therapy modalities and injections, are considered first-line management. High-Intensity Laser Therapy (HILT) is a non-invasive modality with greater tissue penetration compared to low-level laser therapy and has shown promising results in musculoskeletal disorders; however, evidence in GTPS is limited. This study aims to evaluate the efficacy of HILT compared with a sham intervention in patients with GTPS, focusing on pain intensity, functional status, and quality of life.

Frequently Asked Questions

What is HILT in Greater Trochanteric Pain Syndrome?

HILT in Greater Trochanteric Pain Syndrome is a clinical trial registered under NCT07749066. Current status: RECRUITING.

What is the status of NCT07749066?

The current status of NCT07749066 (HILT in Greater Trochanteric Pain Syndrome) is: RECRUITING.

When did HILT in Greater Trochanteric Pain Syndrome start?

HILT in Greater Trochanteric Pain Syndrome started on 2026-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.